Centessa Pharmaceuticals plc (CNTA)

NASDAQ: CNTA · IEX Real-Time Price · USD

6.50

-0.25 (-3.70%)

At close: Nov 27, 2023, 4:00 PM

6.31

-0.19 (-2.92%)

After-hours: Nov 27, 2023, 7:25 PM EST

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019
Selling, General & Admin	55.2	42.89	1.14	0.79
Research & Development	155.08	95.66	9.3	4.26
Other Operating Expenses	-0.36	239.91	0	0
Operating Expenses	209.92	378.45	10.44	5.05
Operating Income	-209.92	-378.45	-10.44	-5.05
Interest Expense / Income	7.03	1.17	0.07	-0.01
Other Expense / Income	-	1.33	0.16	-10.11
Pretax Income	-216.95	-380.96	-10.66	5.06
Income Tax	-0.75	0.11	0	0
Net Income	-216.21	-381.07	-10.66	5.06
Shares Outstanding (Basic)	93	75	86	-
Shares Outstanding (Diluted)	93	75	-	-
Shares Change	24.26%	-12.52%	-	-
EPS (Basic)	-2.31	-5.07	-	-
EPS (Diluted)	-2.31	-5.07	-	-
Free Cash Flow	-201.68	-135.3	-10.63	-5.83
Free Cash Flow Per Share	-2.16	-1.80	-0.12	-
EBITDA	-209.79	-379.75	-10.6	5.06
Depreciation & Amortization	0.13	0.03	0	0.01
EBIT	-209.92	-379.79	-10.6	5.06

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).